CONCLUSION: This study evaluated [177Lu]Lu-PSMA-RLT in early-stage PCa, demonstrating strong PSA decline, prolonged PCa progression-free period, and good tolerability. This evidence concerns the gene FOLH1 and posterior cortical atrophy.